4178 — StemCyte International Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for StemCyte International, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—
Source:	PROSPECTUS	PROSPECTUS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS
Status:	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	517	1,164	2,263
Net Total Accounts Receivable
Net Total Receivables	105	115	141
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,107	1,725	2,865
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	161	164	376
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,491	2,017	3,368
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	231	254	255
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	1,136	1,181	1,418
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	355	836	1,949
Total Liabilities & Shareholders' Equity	1,491	2,017	3,368
Total Common Shares Outstanding